Clinical Trial Update: the Predictors of Hemorrhagic Transformation Subtypes in Acute Embolic Stroke Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial by Kafrelsheikh University investigating predictors of hemorrhagic transformation subtypes in acute embolic stroke patients treated with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Alteplase (alteplase)

Snippet

Sponsor: Kafrelsheikh University | Conditions: Ischemic Stroke, Alteplase Adverse Reaction | Phase 4 | Status: RECRUITING